New MannKind Granted Patent 5/30/2017
Jun 2, 2017 17:50:56 GMT -5
alethea, bioexec25, and 1 more like this
Post by mango on Jun 2, 2017 17:50:56 GMT -5
Dry powder drug delivery system and methods
Type: Grant
Filed: May 2, 2016
Date of Patent: May 30, 2017
Assignee: MannKind Corporation
Inventors: Chad C. Smutney, Benoit Adamo, John M. Polidoro, P. Spencer Kinsey, Dennis Overfield, Carl Sahi, Christine Billings, Mark T. Marino
Abstract: A pulmonary drug delivery system is disclosed, including a breath-powered, dry powder inhaler, and a cartridge for delivering a dry powder formulation. The inhaler and cartridge can be provided with a drug delivery formulation comprising, for example, a diketopiperazine and an active ingredient, including, small organic molecules, peptides and proteins, including, insulin and glucagon-like peptide 1 for the treatment of disease and disorders, for example, endocrine disease such as diabetes and/or obesity.
patents.justia.com/patent/9662461
Type: Grant
Filed: May 2, 2016
Date of Patent: May 30, 2017
Assignee: MannKind Corporation
Inventors: Chad C. Smutney, Benoit Adamo, John M. Polidoro, P. Spencer Kinsey, Dennis Overfield, Carl Sahi, Christine Billings, Mark T. Marino
Abstract: A pulmonary drug delivery system is disclosed, including a breath-powered, dry powder inhaler, and a cartridge for delivering a dry powder formulation. The inhaler and cartridge can be provided with a drug delivery formulation comprising, for example, a diketopiperazine and an active ingredient, including, small organic molecules, peptides and proteins, including, insulin and glucagon-like peptide 1 for the treatment of disease and disorders, for example, endocrine disease such as diabetes and/or obesity.
patents.justia.com/patent/9662461